Replies to post #57454 on Biotech Values

[masterlongevity]

BIIB announced earlier this month that avonex is still the #1 sold MS drug? is this still correct?

[DewDiligence]

Annualized 4Q07 Copaxone sales by region
(as reported by Teva):

US: $1.08B (62% of total), +13% YoY, -4% QoQ
ex-US: $664M (38% of total), +19% YoY, +4% QoQ
===
Total: $1.74B, +15% YoY, -1% QoQ

http://biz.yahoo.com/bw/080212/20080211006686.html